Literature DB >> 12117913

Lipopolysaccharide-binding protein- and CD14-dependent activation of mitogen-activated protein kinase p38 by lipopolysaccharide in human neutrophils is associated with priming of respiratory burst.

Sen Rong Yan1, Walla Al-Hertani, David Byers, Robert Bortolussi.   

Abstract

Neutrophil (PMN) functions can be primed for greatly increased oxidative radical release by exposure to certain agents such as lipopolysaccharide (LPS). Although a variety of signaling pathways involving both tyrosine kinases and mitogen-activated protein (MAP) kinases may be operative, the mechanisms of PMN priming are still not understood. We found that PMN priming was not achieved by treatment of cells with a very low concentration (5 ng/ml) of LPS unless additional "helper" factors were present in plasma (5%). Under these conditions, LPS induced tyrosine phosphorylation of a 38-kDa protein, which was coincident with the MAP kinase p38 action in this situation. LPS-mediated activation of p38 in human PMNs was dependent on the presence of LPS binding protein from plasma and CD14 on the surfaces of the cells. Phosphorylation of p38 was highly correlated with LPS priming of a formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated PMN respiratory burst. Treatment of PMN with the p38-specific inhibitor SB203580 significantly attenuated the respiratory burst in cells primed by LPS and stimulated by fMLP. These results suggest that the LPS signaling pathway leading to p38 activation may be an important mechanism in regulation of PMN priming. The mediator(s) linking CD14 to p38 involves proteins that are functionally sensitive to genistein but insensitive to tyrphostin AG126 and to Src- and Syk-family kinase, protein kinase C, and phosphatidylinositol 3-kinase inhibitors. Elucidating this pathway will provide insight into possible regulation of PMN priming by LPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117913      PMCID: PMC128158          DOI: 10.1128/IAI.70.8.4068-4074.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Activation of extracellular signal-related protein kinases 1 and 2 of the mitogen-activated protein kinase family by lipopolysaccharide requires plasma in neutrophils from adults and newborns.

Authors:  S Bonner; S R Yan; D M Byers; R Bortolussi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  TIRAP: how Toll receptors fraternize.

Authors:  P Henneke; D T Golenbock
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

Review 3.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

4.  IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.

Authors:  A Verbon; P E Dekkers; T ten Hove; C E Hack; J P Pribble; T Turner; S Souza; T Axtelle; F J Hoek; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells.

Authors:  E P Salazar; E Rozengurt
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

6.  TNF alpha primes polymorphonuclear leukocytes for an enhanced respiratory burst to a similar extent as bacterial lipopolysaccharide.

Authors:  R E Schopf; R Keller; M Rehder; P Benes; F Kallinowski; P Vaupel
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

7.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

8.  Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases.

Authors:  A Mócsai; Z Jakus; T Vántus; G Berton; C A Lowell; E Ligeti
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

9.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme.

Authors:  L A Guthrie; L C McPhail; P M Henson; R B Johnston
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  13 in total

1.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

2.  Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Daniel E Sturdevant; Devon L Rasmussen; Liliya N Kirpotina; Mark T Quinn; Frank R DeLeo
Journal:  J Leukoc Biol       Date:  2012-05-11       Impact factor: 4.962

3.  Effects of Endotoxin Tolerance Induced by Porphyromonas gingivalis Lipopolysaccharide on Inflammatory Responses in Neutrophils.

Authors:  Jian-Yu Gu; Yu-Jie Liu; Xiang-Qing Zhu; Jia-Ying Qiu; Ying Sun
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

4.  The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection.

Authors:  T Bruns; J Peter; S Hagel; A Herrmann; A Stallmach
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

5.  Role of protein tyrosine kinase p53/56lyn in diminished lipopolysaccharide priming of formylmethionylleucyl- phenylalanine-induced superoxide production in human newborn neutrophils.

Authors:  Sen Rong Yan; David M Byers; Robert Bortolussi
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

7.  Uropathogenic Escherichia coli triggers oxygen-dependent apoptosis in human neutrophils through the cooperative effect of type 1 fimbriae and lipopolysaccharide.

Authors:  Robert Blomgran; Limin Zheng; Olle Stendahl
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions.

Authors:  Stefan Bernhard; Stefan Hug; Alexander Elias Paul Stratmann; Maike Erber; Laura Vidoni; Christiane Leonie Knapp; Bertram Dietrich Thomaß; Michael Fauler; Bo Nilsson; Kristina Nilsson Ekdahl; Karl Föhr; Christian Karl Braun; Lisa Wohlgemuth; Markus Huber-Lang; David Alexander Christian Messerer
Journal:  J Innate Immun       Date:  2021-04-15       Impact factor: 7.349

9.  PRBC-derived plasma induces non-muscle myosin type IIA-mediated neutrophil migration and morphologic change.

Authors:  Chen Yu; Li Xu; Lii-fang Chen; Ying-jie Guan; Minsoo Kim; Walter L Biffl; Y Eugene Chin
Journal:  Immunopharmacol Immunotoxicol       Date:  2012-10-19       Impact factor: 2.730

10.  The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

Authors:  Riny Janssen; Annelies van Wengen; Marieke A Hoeve; Monique ten Dam; Miriam van der Burg; Jacques van Dongen; Esther van de Vosse; Maarten van Tol; Robbert Bredius; Tom H Ottenhoff; Corry Weemaes; Jaap T van Dissel; Arjan Lankester
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.